Glen Weiss to Cisplatin
This is a "connection" page, showing publications Glen Weiss has written about Cisplatin.
Connection Strength
0.163
-
Shapiro GI, Tibes R, Gordon MS, Wong BY, Eder JP, Borad MJ, Mendelson DS, Vogelzang NJ, Bastos BR, Weiss GJ, Fernandez C, Sutherland W, Sato H, Pierceall WE, Weaver D, Slough S, Wasserman E, Kufe DW, Von Hoff D, Kawabe T, Sharma S. Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors. Clin Cancer Res. 2011 May 15; 17(10):3431-42.
Score: 0.083
-
Weiss GJ. Thymic carcinoma: current and future therapeutic interventions. Expert Opin Investig Drugs. 2010 Aug; 19(8):1007-16.
Score: 0.080